Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board changes and trading update

30 Jan 2015 07:00

RNS Number : 5581D
Plant Health Care PLC
30 January 2015
 



30 Jan 2015

 

PLANT HEALTH CARE plc

 

("Plant Health Care" or the "Company")

 

Board changes and trading update

Plant Health Care announces organisation changes and a pre-close trading statement in respect of the year ended 31 December 2014.

Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to the global agriculture markets, is pleased to announce that Dr. Richard Webb, formerly a Non-Executive Director, has become an Executive Director of Plant Health Care plc. Richard will be responsible for supporting the Chief Scientific Officer, Dr. Zhongmin Wei, as the company continues to expand its research and development programme.

Richard will step down from the Audit Committee and be replaced by James Ede-Golightly. In due course, the company intends to appoint an additional independent non-executive director with extensive commercial experience in the sector.

During 2014, the Company continued to make substantial progress in our core research objectives, as evidenced by the launch of the Innatus 3G™ technology platform. Major industry players have responded positively to Innatus 3G and we are in active discussions with them as we pursue potential partnerships. Our intellectual property portfolio continues to strengthen our leading position in protein-based bio-stimulants. Regarding our existing products, we have added material new distribution agreements over recent months, which we anticipate will lead to further sales growth as registrations are obtained outside current markets. We are actively exploring options to extend and accelerate sales further.

Revenue for the year ended 31 December 2014 amounted to $6.9 million, of which $0.15 million was one-off milestone payments. The company's sales of proprietary products (excluding one-off payments) grew 40% over 2013 with combined sales of Harpin and Myconate reaching $3.5 million.

Cash and investments at the year-end were $16.7 million.

More details will be provided in the announcement of the Company's 2014 results, scheduled for 30 March 2015.

- ENDS -

For further information, please contact:

Plant Health Care plc

Paul Schmidt, Chief Executive Officer Tel: +1 (919) 926 1600

 

Liberum Capital - Nomad and Broker

Clayton Bush Tel: +44 (0) 20 3100 2000

 

LHA

Ed McGregor / Jody Burfening Tel: +1 (212) 838 3777

 

Company website: www.planthealthcare.com

 

About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEADFNAEESEAF
Date   Source Headline
2nd Jul 20242:23 pmRNSForm 8.3 - Plant Health Care plc
1st Jul 20249:46 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 20247:32 amRNSForm 8.3 - Plant Health Care plc
28th Jun 20241:38 pmRNSForm 8.3 - Plant Health Care PLC
28th Jun 202411:35 amRNSForm 8.3 - Plant Health Care plc
28th Jun 202411:31 amRNSResult of GM & AGM
28th Jun 202410:13 amRNSForm 8.3 - Plant Health Care Plc
28th Jun 20249:16 amRNSForm 8.5 (EPT/NON-RI)
28th Jun 20248:59 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20241:03 pmPRNForm 8.3 - Plant Health Care Plc
27th Jun 202412:13 pmRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:43 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:08 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 20245:55 pmRNSForm 8.3 - Plant Health Care
26th Jun 20241:23 pmRNSRecommended Cash Acquisition of Plant Health Care
12th Jun 20245:22 pmRNSNotice of General Meeting
5th Jun 20245:09 pmRNSNotice of Annual General Meeting
4th Jun 20247:00 amRNSExpanded New California Label for Employ®
31st May 20245:05 pmRNSFull Year Results
16th May 20242:24 pmRNSHolding(s) in Company
14th May 20242:58 pmRNSHolding(s) in Company
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.